Related Experiment Video
Updated: Oct 6, 2026
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia
C Da Cunha1, M S Gevaerd, M A Vital
1Laboratório de Fisiologia e Farmacologia do SNC, Departamento de Farmacologia, UFPR, CP.: 19.031, 81.531-990 Curitiba PR, Brazil. dacunha@bio.ufpr.br
Abstract:
Intra-nigral administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) caused a lesion in the substantia nigra, compact part (SNc) and a specific loss of dopamine and its metabolites in the striatum of rats. The animals were then tested in the two-way active avoidance task. MPTP-treated animals presented lower learning scores in the training and test sessions, an effect that was not caused by motor impairment or by a decreased sensitivity to footshock since their reaction time to the footshock (unconditioned stimulus - UCS) was not reduced. These lower scores were also not attributable to lower acoustic sensitivity or to a slowing in the association of the sound cue (conditioned stimulus - CS) with the UCS since the reaction time to the CS in the active avoidance response did not differ between MPTP-treated and control groups. Therefore, these results are more properly attributable to an impairment of the memory acquisition and retention processes. In addition, this study is presented as a model of early Parkinson's Disease amnesia and is discussed in terms of the importance of the nigrostriatal pathway to memory acquisition and storage processes.
Insights
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rats impairs memory acquisition and retention, not motor function. This MPTP-induced memory deficit models early Parkinson's disease amnesia.
Area of Science:
- Neuroscience
- Neuropharmacology
- Behavioral Neuroscience
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that selectively destroys dopaminergic neurons in the substantia nigra, compact part (SNc).
- Dopaminergic pathways, particularly the nigrostriatal pathway, are implicated in motor control and cognitive functions, including memory.
Purpose of the Study:
- To investigate the effects of MPTP-induced SNc lesions on learning and memory in a two-way active avoidance task in rats.
- To determine if observed behavioral deficits are due to motor impairment or a genuine impairment in memory processes.
- To establish a rat model for studying early Parkinson's disease-related amnesia.
Main Methods:
- Intra-nigral administration of MPTP to induce SNc lesions in rats.
- Assessment of motor function and sensory sensitivity (footshock and acoustic stimuli).
- Testing animals in a two-way active avoidance task to evaluate learning and memory acquisition/retention.
Main Results:
- MPTP treatment resulted in significant lesions in the SNc and reduced dopamine levels in the striatum.
- MPTP-treated rats exhibited lower learning scores in the active avoidance task.
- No significant motor impairment, reduced sensitivity to footshock, or altered acoustic sensitivity was observed in MPTP-treated rats.
- Reaction times to conditioned and unconditioned stimuli were not significantly different between groups, suggesting intact sensory processing and stimulus-response association.
Conclusions:
- MPTP-induced SNc lesions impair memory acquisition and retention processes in rats.
- The observed cognitive deficits are not attributable to motor impairments or sensory processing deficits.
- The MPTP-lesioned rat serves as a valuable model for studying the amnesic effects associated with early Parkinson's disease and the role of the nigrostriatal pathway in memory.
